PCI Biotech
CONTACT US
ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION
TECHNOLOGY PIPELINE PARTNERING
INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE
ABOUT US ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION WHAT WE DO TECHNOLOGY PIPELINE PARTNERING INVESTORS INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE CONTACT US
PCI Biotech
 

NEWS

News archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
 
Open position as Director Clinical Science / Medical Director
NewsRonny SkuggedalJuly 13, 2015
Mandatory notification of trade
NewsRonny SkuggedalJuly 6, 2015
Mandatory notification of trade
NewsRonny SkuggedalJune 8, 2015
Update on the ENHANCE study
NewsRonny SkuggedalJune 3, 2015
PCI Biotech: Minutes from Annual General Meeting 2015
NewsRonny SkuggedalMay 12, 2015
PCI Biotech will be presenting at BioTrinity 2015, Novotel London West, May 11-13, 2015
NewsRonny SkuggedalMay 12, 2015
PCI Biotech: First quarter 2015 Report
NewsRonny SkuggedalMay 12, 2015
Mandatory notification of trade
NewsRonny SkuggedalMay 7, 2015
Capital increase registered and listing of new shares
NewsRonny SkuggedalApril 28, 2015
Mandatory notification of trade - exercise of employee share options
NewsRonny SkuggedalApril 27, 2015
Notice of Annual General Meeting 2015
NewsRonny SkuggedalApril 20, 2015
Mandatory notification of trade - Share option program
NewsRonny SkuggedalApril 20, 2015
PCI Biotech to present at the World Vaccine Congress 2015
NewsRonny SkuggedalApril 8, 2015
PCI Biotech initiates pre-clinical research collaboration in siRNA therapeutics
NewsRonny SkuggedalApril 7, 2015
Annual Report 2014
NewsRonny SkuggedalMarch 24, 2015
PCI Biotech announces positive feedback regarding a patent application in vaccination and immunotherapy
NewsRonny SkuggedalMarch 6, 2015
Fourth quarter and preliminary full year 2014 results
NewsRonny SkuggedalFebruary 24, 2015
Completion of the third group in the intra-tumour light dose escalation part of the ENHANCE study
NewsRonny SkuggedalFebruary 20, 2015
Successful completion of the second dose cohort in the study for patients with inoperable bile duct cancer
NewsRonny SkuggedalFebruary 6, 2015
Preliminary results of the rights issue
NewsRonny SkuggedalFebruary 4, 2015
Newer Older

Privacy policy I Contact us
©COPYRIGHT PCI BIOTECH. ALL RIGHTS RESERVED